(NUE) Nucor - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6703461052
Stock: Steel Mills, Steel Products, Raw Materials
Total Rating 48
Risk 78
Buy Signal -0.44
| Risk 5d forecast | |
|---|---|
| Volatility | 31.2% |
| Relative Tail Risk | -8.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.96 |
| Alpha | 12.53 |
| Character TTM | |
|---|---|
| Beta | 1.150 |
| Beta Downside | 1.853 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.79% |
| CAGR/Max DD | 0.04 |
EPS (Earnings per Share)
Revenue
Description: NUE Nucor March 04, 2026
Nucor Corporation (NUE) manufactures and sells steel and steel products through three segments: Steel Mills, Steel Products, and Raw Materials. The companys operations are vertically integrated, a common strategy in heavy industry to control supply chains.
The Steel Mills segment produces various steel forms, including sheet, plate, structural, and bar steel, selling to service centers, fabricators, and manufacturers across North America. The Steel Products segment offers a diverse range of fabricated steel items, such as joists, decks, and tubing, for construction and infrastructure. The Raw Materials segment focuses on direct reduced iron (DRI) production, scrap metal processing, and metal brokerage, supplying materials for steel production. This segments activities highlight the role of recycled content in modern steelmaking.
Nucor, founded in 1905 and headquartered in Charlotte, North Carolina, operates within the Steel GICS Sub Industry.
For a deeper dive into Nucors financial performance and market position, consider exploring ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 1.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -2.91 > 1.0 |
| NWC/Revenue: 23.88% < 20% (prev 24.40%; Δ -0.51% < -1%) |
| CFO/TA 0.09 > 3% & CFO 3.23b > Net Income 1.74b |
| Net Debt (4.86b) to EBITDA (4.20b): 1.16 < 3 |
| Current Ratio: 2.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (229.6m) vs 12m ago -2.01% < -2% |
| Gross Margin: 11.93% > 18% (prev 0.13%; Δ 1180 % > 0.5%) |
| Asset Turnover: 94.13% > 50% (prev 90.55%; Δ 3.57% > 0%) |
| Interest Coverage Ratio: 18.23 > 6 (EBITDA TTM 4.20b / Interest Expense TTM 149.0m) |
Altman Z'' 7.45
| A: 0.22 (Total Current Assets 11.77b - Total Current Liabilities 4.00b) / Total Assets 35.10b |
| B: 0.90 (Retained Earnings 31.50b / Total Assets 35.10b) |
| C: 0.08 (EBIT TTM 2.72b / Avg Total Assets 34.52b) |
| D: 2.42 (Book Value of Equity 31.46b / Total Liabilities 12.98b) |
| Altman-Z'' Score: 7.45 = AAA |
Beneish M -2.87
| DSRI: 1.10 (Receivables 3.10b/2.67b, Revenue 32.49b/30.73b) |
| GMI: 1.12 (GM 11.93% / 13.35%) |
| AQI: 0.94 (AQ_t 0.23 / AQ_t-1 0.24) |
| SGI: 1.06 (Revenue 32.49b / 30.73b) |
| TATA: -0.04 (NI 1.74b - CFO 3.23b) / TA 35.10b) |
| Beneish M-Score: -2.87 (Cap -4..+1) = A |
What is the price of NUE shares?
As of March 05, 2026, the stock is trading at USD 176.07 with a total of 750,730 shares traded.
Over the past week, the price has changed by +0.34%, over one month by -7.31%, over three months by +8.69% and over the past year by +38.17%.
Over the past week, the price has changed by +0.34%, over one month by -7.31%, over three months by +8.69% and over the past year by +38.17%.
Is NUE a buy, sell or hold?
Nucor has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy NUE.
- StrongBuy: 5
- Buy: 5
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NUE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 186.1 | 5.7% |
| Analysts Target Price | 186.1 | 5.7% |
NUE Fundamental Data Overview March 01, 2026
P/E Trailing = 23.5213
P/E Forward = 16.0256
P/S = 1.2458
P/B = 1.9197
P/EG = 0.75
Revenue TTM = 32.49b USD
EBIT TTM = 2.72b USD
EBITDA TTM = 4.20b USD
Long Term Debt = 6.69b USD (from longTermDebt, two quarters ago)
Short Term Debt = 212.0m USD (from shortTermDebt, last quarter)
Debt = 7.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.86b USD (from netDebt column, last quarter)
Enterprise Value = 44.90b USD (40.48b + Debt 7.12b - CCE 2.70b)
Interest Coverage Ratio = 18.23 (Ebit TTM 2.72b / Interest Expense TTM 149.0m)
EV/FCF = -238.8x (Enterprise Value 44.90b / FCF TTM -188.0m)
FCF Yield = -0.42% (FCF TTM -188.0m / Enterprise Value 44.90b)
FCF Margin = -0.58% (FCF TTM -188.0m / Revenue TTM 32.49b)
Net Margin = 5.37% (Net Income TTM 1.74b / Revenue TTM 32.49b)
Gross Margin = 11.93% ((Revenue TTM 32.49b - Cost of Revenue TTM 28.62b) / Revenue TTM)
Gross Margin QoQ = 11.21% (prev 13.94%)
Tobins Q-Ratio = 1.28 (Enterprise Value 44.90b / Total Assets 35.10b)
Interest Expense / Debt = 0.15% (Interest Expense 11.0m / Debt 7.12b)
Taxrate = 15.57% (78.0m / 501.0m)
NOPAT = 2.29b (EBIT 2.72b * (1 - 15.57%))
Current Ratio = 2.94 (Total Current Assets 11.77b / Total Current Liabilities 4.00b)
Debt / Equity = 0.34 (Debt 7.12b / totalStockholderEquity, last quarter 20.94b)
Debt / EBITDA = 1.16 (Net Debt 4.86b / EBITDA 4.20b)
Debt / FCF = -25.86 (negative FCF - burning cash) (Net Debt 4.86b / FCF TTM -188.0m)
Total Stockholder Equity = 20.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.05% (Net Income 1.74b / Total Assets 35.10b)
RoE = 8.49% (Net Income TTM 1.74b / Total Stockholder Equity 20.54b)
RoCE = 9.98% (EBIT 2.72b / Capital Employed (Equity 20.54b + L.T.Debt 6.69b))
RoIC = 8.31% (NOPAT 2.29b / Invested Capital 27.61b)
WACC = 8.65% (E(40.48b)/V(47.60b) * Re(10.15%) + D(7.12b)/V(47.60b) * Rd(0.15%) * (1-Tc(0.16)))
Discount Rate = 10.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.88%
[DCF] Fair Price = unknown (Cash Flow -188.0m)
EPS Correlation: -81.39 | EPS CAGR: -33.73% | SUE: -1.94 | # QB: 0
Revenue Correlation: -76.19 | Revenue CAGR: -7.96% | SUE: -0.49 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.30 | Chg7d=+0.314 | Chg30d=+0.189 | Revisions Net=+3 | Analysts=4
EPS current Year (2026-12-31): EPS=11.86 | Chg7d=-0.009 | Chg30d=+0.144 | Revisions Net=+2 | Growth EPS=+57.8% | Growth Revenue=+9.8%
EPS next Year (2027-12-31): EPS=13.39 | Chg7d=+0.026 | Chg30d=+0.694 | Revisions Net=+2 | Growth EPS=+12.8% | Growth Revenue=+3.6%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.9% (Discount Rate 10.2% - Earnings Yield 4.3%)
[Growth] Growth Spread = +4.1% (Analyst 10.0% - Implied 5.9%)
P/E Forward = 16.0256
P/S = 1.2458
P/B = 1.9197
P/EG = 0.75
Revenue TTM = 32.49b USD
EBIT TTM = 2.72b USD
EBITDA TTM = 4.20b USD
Long Term Debt = 6.69b USD (from longTermDebt, two quarters ago)
Short Term Debt = 212.0m USD (from shortTermDebt, last quarter)
Debt = 7.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.86b USD (from netDebt column, last quarter)
Enterprise Value = 44.90b USD (40.48b + Debt 7.12b - CCE 2.70b)
Interest Coverage Ratio = 18.23 (Ebit TTM 2.72b / Interest Expense TTM 149.0m)
EV/FCF = -238.8x (Enterprise Value 44.90b / FCF TTM -188.0m)
FCF Yield = -0.42% (FCF TTM -188.0m / Enterprise Value 44.90b)
FCF Margin = -0.58% (FCF TTM -188.0m / Revenue TTM 32.49b)
Net Margin = 5.37% (Net Income TTM 1.74b / Revenue TTM 32.49b)
Gross Margin = 11.93% ((Revenue TTM 32.49b - Cost of Revenue TTM 28.62b) / Revenue TTM)
Gross Margin QoQ = 11.21% (prev 13.94%)
Tobins Q-Ratio = 1.28 (Enterprise Value 44.90b / Total Assets 35.10b)
Interest Expense / Debt = 0.15% (Interest Expense 11.0m / Debt 7.12b)
Taxrate = 15.57% (78.0m / 501.0m)
NOPAT = 2.29b (EBIT 2.72b * (1 - 15.57%))
Current Ratio = 2.94 (Total Current Assets 11.77b / Total Current Liabilities 4.00b)
Debt / Equity = 0.34 (Debt 7.12b / totalStockholderEquity, last quarter 20.94b)
Debt / EBITDA = 1.16 (Net Debt 4.86b / EBITDA 4.20b)
Debt / FCF = -25.86 (negative FCF - burning cash) (Net Debt 4.86b / FCF TTM -188.0m)
Total Stockholder Equity = 20.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.05% (Net Income 1.74b / Total Assets 35.10b)
RoE = 8.49% (Net Income TTM 1.74b / Total Stockholder Equity 20.54b)
RoCE = 9.98% (EBIT 2.72b / Capital Employed (Equity 20.54b + L.T.Debt 6.69b))
RoIC = 8.31% (NOPAT 2.29b / Invested Capital 27.61b)
WACC = 8.65% (E(40.48b)/V(47.60b) * Re(10.15%) + D(7.12b)/V(47.60b) * Rd(0.15%) * (1-Tc(0.16)))
Discount Rate = 10.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.88%
[DCF] Fair Price = unknown (Cash Flow -188.0m)
EPS Correlation: -81.39 | EPS CAGR: -33.73% | SUE: -1.94 | # QB: 0
Revenue Correlation: -76.19 | Revenue CAGR: -7.96% | SUE: -0.49 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.30 | Chg7d=+0.314 | Chg30d=+0.189 | Revisions Net=+3 | Analysts=4
EPS current Year (2026-12-31): EPS=11.86 | Chg7d=-0.009 | Chg30d=+0.144 | Revisions Net=+2 | Growth EPS=+57.8% | Growth Revenue=+9.8%
EPS next Year (2027-12-31): EPS=13.39 | Chg7d=+0.026 | Chg30d=+0.694 | Revisions Net=+2 | Growth EPS=+12.8% | Growth Revenue=+3.6%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.9% (Discount Rate 10.2% - Earnings Yield 4.3%)
[Growth] Growth Spread = +4.1% (Analyst 10.0% - Implied 5.9%)